IMTH — Innovative Medtech Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesHighly SpeculativeMicro Cap

Annual income statement for Innovative Medtech, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2010 October 31st	2011 October 31st	2012 October 31st	2013 October 31st	2014 October 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K/A	10-K	10-K	10-K	10-K
Standards:	USG	USG	U USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.645	0.668	0	0	0
Cost of Revenue
Gross Profit	0.087	0.162	0	0	0
Selling / General / Administrative Expenses
Unusual Expense / Income
Total Operating Expenses	2.56	1.62	1.3	0.284	0.336
Operating Profit	-1.92	-0.955	-1.3	-0.284	-0.336
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Net Income Before Taxes	-2.02	-1.05	-1.46	-0.567	-0.365
Provision for Income Taxes
Net Income After Taxes	-2.02	-1.05	-1.46	-0.567	-0.365
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-2.02	-1.05	-1.49	-0.567	-0.365
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-2.02	-1.05	-1.49	-0.567	-0.365
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-87.7	-43.9	-16.2	-3.47	-2.23
Dividends per Share